While higher lifetime antipsychotic exposure has been associated with poorer cognition in patients with schizophrenia, the effects of adjunctive psychiatric medication use and lifetime trends are not well...
In a recent study, researchers sought to determine whether routine testing of patients who presented to emergency departments with chest pain but without evidence of ischemia influenced admission rates for...
In a recent study, researchers compared the safety and efficacy of 2 drugs for adults with acute exacerbations of schizophrenia. To see results of the study, including which drugs were evaluated, read...
Schizophrenia patients taking antipsychotics face a greater risk of cardiovascular disease. In a recent study, researchers tested the effects of a glucagon-like peptide-1 receptor agonist in schizophrenia...
The findings of a recent study challenge the hypothesis that schizophrenia and other cognitive impairments are associated with GABA deficiency. The study compared the brain chemistry of schizophrenia...
Penn State recently released some results from the ongoing PATH study regarding users’ dependency on e-cigarettes and regular cigarettes. To see the current results, as well as future plans for the PATH...
In a new study, researchers aimed to determine the effects of a diabetes drug added to clozapine or olanzapine treatment for schizophrenia. To see the results, including how the drug affected...
Aristada recently received approval from the US Food and Drug Administration for a new and shorter dosing regimen, providing more options to patients and health care providers.
Inappropriate antibiotic use is a contributing factor to rising antibiotic resistance rates. A recent study examined trends in antibiotic prescriptions for acute respiratory tract infections to determine if...
